Effects of neopterin and 7,8-dihydroneopterin on hypoxia-induced renal erythropoietin production.
Activation of the human cellular immune system is associated with greatly increased formation of the pteridines neopterin and 7,8-dihydroneopterin. It has been postulated that pteridines play a role in the pathogenesis of the anaemia of inflammation. Herein, we studied effects of pteridines on renal function, primarily on the synthesis of erythropoietin (Epo). The experiments were performed with isolated rat kidneys which were perfused hypoxically (pO2 26 mmHg) at constant pressure (100 mmHg) in a serum-free recirculation system for 3 h. The results show that the rate of the production of Epo was significantly lowered when neopterin or 7,8-dihydroneopterin were added to the perfusate. Neopterin (200 microM) also reduced the renal Epo mRNA level. Both pteridines increased renal vascular resistance. 7,8-Dihydroneopterin lowered urine flow and glomerular filtration rate more potently than neopterin. Renal O2 consumption and parameters of exocrine renal function (fractional reabsorption rates of sodium, glucose and water) were not altered by the pteridines, while the glomerular permeability was greatly increased. These results suggest that activated macrophages may not only inhibit the synthesis of Epo by generating cytokines and reactive O2 species but also by the release of pteridines. In vivo, high concentrations of pteridines in renal tissue may aggravate the anaemia of inflammation.
Pagel
H
H
Institute of Physiology, Medical University, Lübeck, Germany. Pagel@physio.mu-luebeck.de
Fandrey
J
J
Schobersberger
W
W
Fuchs
D
D
Jelkmann
W
W
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D015687:Cell Hypoxia; D004797:Enzyme-Linked Immunosorbent Assay; D004921:Erythropoietin / Q000096:biosynthesis*; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D019798:Neopterin / Q000494:pharmacology* / Q000031:analogs & derivatives; D016133:Polymerase Chain Reaction; D011621:Pteridines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley
D000975:Antioxidants; D011621:Pteridines; D012333:RNA, Messenger; D004921:Erythropoietin; C000976:7,8-dihydroneopterin; D019798:Neopterin